MedPath

Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After TKA: A Prospective RCT

Not Applicable
Completed
Conditions
Osteoarthritis of Knee
Interventions
Other: Drain clamping and tranexamic acid
Other: No clamp and placebo
Procedure: Drain clamping
Registration Number
NCT01449552
Lead Sponsor
Mahidol University
Brief Summary

Total knee arthroplasty (TKA) may be associated with significant blood loss, and transfusion carries substantial risk of immunologic reaction and disease transmission. Several methods reportedly reduce postoperative blood loss and avoid homologous blood transfusion with traditional TKA approaches. Drain clamping was one of the widely used method and tranexamic acid administration was the recently adjuvant method to reduce blood loss in TKA. However, there were several regimens in either drain clamping or tranexamic acid administration reported in previous studies. Our objective was to compare the efficacy of our drain clamping protocol and/or tranexamic acid regimen for reducing blood loss and transfusion in TKA.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
240
Inclusion Criteria
  • The patients younger than 85 years with knee osteoarthritis
Exclusion Criteria
  • The patient diagnosed secondary osteoarthritis (eg, rheumatoid arthritis, posttraumatic arthritis, gouty arthritis, postseptic arthritis)
  • High-risk medical comorbid patient
  • The patient who was planed for simultaneous bilateral TKAs
  • The patient who had history of thromboembolic disease or bleeding disorder
  • The patient who was receiving anticoagulant drug treatment
  • The patient who had allergy to tranexamic acid

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group DDrain clamping and tranexamic acidDrain clamping and tranexamic acid
Group ANo clamp and placeboNo clamp and placebo
Group CDrain clampingDrain clamping
Group BTranexamic acidTranexamic acid
Primary Outcome Measures
NameTimeMethod
Postoperative blood loss48 hours after operation
Secondary Outcome Measures
NameTimeMethod
Number of blood transfusion5 days
Ā© Copyright 2025. All Rights Reserved by MedPath